<DOC>
	<DOCNO>NCT00711841</DOCNO>
	<brief_summary>Corticotherapy accelerate maternal postpartum recovery woman class I HELLP syndrome . The benefit faster good recovery would observe few complication , less utilization blood product shorter hospital stay .</brief_summary>
	<brief_title>Effectivity Postpartum Dexamethasone Women With Class I HELLP Syndrome</brief_title>
	<detailed_description>Patients Class I HELLP Syndrome recruit use o dexamethasone placebo puerperium . Effects clinical course ( blood pressure diureses ) , laboratorial behaviour complication compare . Duration hospitalization also access .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>HELLP Syndrome</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Postpartum woman Class I HELLP syndrome Chronic user corticosteroids Patients chronic condition affect laboratory parameter involve HELLP syndrome Women receive antenatal corticosteroid treat HELLP syndrome exclude</criteria>
	<gender>Female</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>HELLP syndrome</keyword>
	<keyword>dexamethasone</keyword>
	<keyword>postpartum period</keyword>
	<keyword>class I HELLP syndrome</keyword>
</DOC>